UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,984,792 | – | 3,470,688 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 76,645 | $64,000 | 0.10% |
| Nantahala Capital Management | 729,680 | $606,000 | 0.03% |
| Board of Trustees of The Leland Stanford Junior University | 247,583 | $205,000 | 0.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 15,500 | $13,000 | 0.01% |
| FineMark National Bank & Trust | 15,625 | $13,000 | 0.00% |
| Frontier Wealth Management LLC | 18,800 | $16,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,109 | $21,000 | 0.00% |
| Citadel Advisors | 15,210 | $13,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,167 | $4,000 | 0.00% |